This basic science study maps the protein-binding domains of U2 and U4/U6 snRNPs in Trypanosoma brucei, highlighting trans-spliceosomal specific RNA-protein interactions.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications in cardiology; leaves open selective targeting of trans-spliceosomal domains for antiparasitic therapies.
Maturation of mRNAs in trypanosomes involves trans splicing of the 5' end of the spliced leader RNA and the exons of polycistronic pre-mRNAs, requiring small nuclear ribonucleoproteins (snRNPs) as cofactors. We have mapped protein-binding sites in the U2 and U4/U6 snRNPs by a combination of RNase H protection analysis, native gel electrophoresis, and CsCl density gradient centrifugation. In the U2 snRNP, protein binding occurs primarily in the 3'-terminal domain; through U2 snRNP reconstitution and chemical modification-interference assays, we have identified discrete positions within stem-loop IV of Trypanosoma brucei U2 RNA that are essential for protein binding; significantly, some of these positions differ from the consensus sequence derived from cis-spliceosomal U2 RNAs. In the U4/U6 snRNP, the major protein-binding region is contained within the 3'-terminal half of U4 RNA. In sum, while the overall domain structure of the U2 and U4/U6 snRNPs is conserved between cis- and trans-splicing systems, our data suggest that there are also trans-spliceosomal specific determinants of RNA-protein binding.
No takes yet. Share an insight, caveat, or question.
Günzl et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: